Connect with us

Health

Competitive multiplex binding assay can monitor SARS-CoV-2 immune responses using nanobodies – News-Medical.Net

Researchers at the Eberhard Karls University and the University of Tübingen in Germany described 11 unique nanobodies (Nbs) specific for the SARS-CoV-2 spike receptor-binding…

Published

on

Article feature image

Measuring the presence and performance of neutralizing antibodies is crucial in the fight against the coronavirus disease 2019 (COVID-19) pandemic. This allows us to glimpse how effective vaccines and antibody therapies are in conferring protective immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Researchers in Germany and the U.S. described 11 unique nanobodies (Nbs) specific for the SARS-CoV-2 spike receptor-binding domain (RBD), of which 8 Nbs potentially inhibit…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Weird dreams train us for the unexpected, says new theory – The Guardian
Article feature image
The areas of the UK where the Indian variant is spreading fastest – Yahoo News Australia